Tensions between Japan and South Korea come as the U.S. and its trading partners are embroiled in a global trade war.Technologyread more
The one-to-eight stock split would mean the current number of ordinary shares — which stands at 4 billion — will increase to 32 billion. It comes ahead of a reported Hong Kong...Asia Marketsread more
Minutes from the Reserve Bank of Australia's monetary policy meeting in July showed the central bank was ready to adjust interest rates if required.Asia Marketsread more
Current and former Tesla employees working in the company's open-air "tent" factory say they felt pressure to take shortcuts to hit aggressive Model 3 production goals,...Technologyread more
China's fiscal spending increased 10.7% in the first six months from a year earlier, the finance ministry said on Tuesday, underlining the government's bid to support the...China Economyread more
The findings by McKinsey and Company come amid a year-long tariff fight between the U.S. and China, which has spilled into areas such as technology and security.China Economyread more
Microsoft's considerable reach into the corporate world isn't something Slack CEO Stewart Butterfield is very concerned about.Technologyread more
Von der Leyen, one of the longest serving ministers in Germany, has tried to woo European lawmakers over the last two weeks.Europe Newsread more
A devastating outbreak of African swine fever that has killed millions of pigs in China is changing attitudes in a country where farm hygiene has often been seen as lax by...Livestockread more
In a closed-door meeting at a Manhattan mansion, executives outlined changes to controversial software that was implicated in two crashes.Aerospace & Defenseread more
President Donald Trump and the RNC are picking up key supporters in the business community who did not back him as a candidate in 2016.2020 Electionsread more
CNBC's Jim Cramer said Wednesday that Mylan's lifesaving EpiPen device shouldn't be only obtainable for the rich.
The pharmaceutical company has been scrutinized by consumers and public officials after reports showed it raised prices for its auto-injection device, which counteracts severe allergic reaction known as anaphylaxis.
"This is something I think there should be some compassionate use for in payout," Cramer said on "Squawk on the Street. " "They should have a subsidy for this thing because it's seconds ... and you have to know how to use it .. and it should not just have to be for rich people."
On Monday, Mylan released a statement saying the company has worked over the past few years to increase "anaphylaxis awareness, preparedness and access to treatment" for those living with the life-threatening allergies.
NBC News reported Monday that a U.S. senator asked the Federal Trade Commission to investigate Mylan's trade practices.